dacarbazine has been researched along with Adenoma, Prolactin-Secreting, Pituitary in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (31.82) | 29.6817 |
| 2010's | 15 (68.18) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Assié, G; Batisse-Lignier, M; Bonnet, F; Borot, S; Bourcigaux, N; Bresson, D; Caron, P; Castinetti, F; Chabre, O; Chanson, P; Cloix, L; Cortet, C; Delemer, B; Desailloud, R; Gaillard, S; Garcia, C; Haissaguerre, M; Jouanneau, E; Jublanc, C; Lasolle, H; Lebrun-Frenay, C; Raverot, G; Reznik, Y; Sadoul, JL; Taillandier, L; Vasiljevic, A; Villa, C | 1 |
| Ahmad, MM; Aldabas, BS; Aljoaib, NN; Almalki, MH; Alotaibi, MJ; Alshahrani, F; Wahedi, TS | 1 |
| Bilbao, I; Egaña, N; García, C; Olaizola, I | 1 |
| De Vos, FYFL; Snijders, TJ; Spliet, WGM; Stades, AME; van der Vlist, A | 1 |
| Chen, C; Hu, Y; Jiang, S; Wang, M; Yin, S; Zhang, S; Zhou, P | 1 |
| Barkhoudarian, G; Eisenberg, A; Kelly, DF; Ogunbameru, R; Palejwala, SK; Wei, H | 1 |
| Jouanneau, E; Raverot, G; Trouillas, J | 1 |
| Laterra, JJ; Salvatori, R; Strowd, RE | 1 |
| Halevy, C; Whitelaw, BC | 1 |
| Felker, J; Janss, A; Patterson, B; Wrubel, D | 1 |
| Andersen, M; Hagen, C; Hansen, S; Schroeder, HD | 1 |
| Matsuno, A | 1 |
| Byrne, S; Karapetis, C; Vrodos, N | 1 |
| Grimsdale, R; Han, S; Nguyen, J; Rainey, J; Sheehan, J | 1 |
| Assaker, R; Bernier, M; Borson-Chazot, F; Brue, T; Caron, P; Chabre, O; Chanson, P; Cornélius, A; Cortet-Rudelli, C; de Fraipont, F; Dufour, H; Figarella-Branger, D; François, P; Gaillard, S; Jouanneau, E; Muller, M; Passagia, JG; Raverot, G; Salenave, S; Sturm, N; Trouillas, J | 1 |
| Aghi, MK; Oh, MC | 1 |
| Asano, S; Ishida, Y; Katakami, H; Matsuno, A; Mizutani, A; Murakami, M; Okinaga, H; Ozawa, Y; Takano, K; Yamazaki, K | 1 |
| Aylwin, SJ; Barazi, S; Buchanan, CR; Dworakowska, D; Gilbert, JA; Hampton, T; King, AP; Landau, DB; Lipscomb, D; Riordan-Eva, P; Thomas, NW; Whitelaw, BC | 1 |
| Argon, D; Basa, S; Seçkinel, SA; Tecimer, T; Varol, A | 1 |
| Fadul, CE; Horvath, E; Kovacs, K; Ortiz, LD; Penagos, LC; Syro, LV; Uribe, H | 2 |
| Cole, A; Hedges, TR; Lawrence, D; Lechan, RM; Neff, LM; Shucart, W; Tischler, AS; Weil, M; Zhu, JJ | 1 |
7 review(s) available for dacarbazine and Adenoma, Prolactin-Secreting, Pituitary
| Article | Year |
|---|---|
Temozolomide therapy for resistant prolactin-secreting pituitary adenomas and carcinomas: a systematic review.
Topics: Antineoplastic Agents, Alkylating; Carcinoma; Dacarbazine; Humans; Pituitary Neoplasms; Prolactinoma; Temozolomide | 2017 |
Early Recognition and Initiation of Temozolomide Chemotherapy for Refractory, Invasive Pituitary Macroprolactinoma with Long-Term Sustained Remission.
Topics: Antineoplastic Agents, Alkylating; Dacarbazine; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Pituitary Neoplasms; Prolactinoma; Temozolomide; Time | 2018 |
Management of endocrine disease: clinicopathological classification and molecular markers of pituitary tumours for personalized therapeutic strategies.
Topics: ACTH-Secreting Pituitary Adenoma; Adenoma; Adrenocorticotropic Hormone; Antineoplastic Agents, Alkylating; Biomarkers, Tumor; Dacarbazine; Follicle Stimulating Hormone; Growth Hormone-Secreting Pituitary Adenoma; Human Growth Hormone; Humans; Luteinizing Hormone; Pituitary Hormones, Anterior; Pituitary Neoplasms; Prognosis; Prolactin; Prolactinoma; Temozolomide; Thyrotropin | 2014 |
How effective is temozolomide for treating pituitary tumours and when should it be used?
Topics: Antineoplastic Agents, Alkylating; Dacarbazine; Humans; O(6)-Methylguanine-DNA Methyltransferase; Pituitary Neoplasms; Prolactinoma; Temozolomide; Treatment Outcome | 2017 |
[Recent trends in the pathophysiology and treatment of pituitary adenomas].
Topics: Adenoma; Antineoplastic Agents; Cabergoline; Corticotropin-Releasing Hormone; Dacarbazine; Ergolines; Growth Hormone-Releasing Hormone; Human Growth Hormone; Humans; Hypothalamic Hormones; Incidental Findings; Neurosurgical Procedures; Octreotide; Pituitary Neoplasms; Prolactinoma; Receptors, Neuropeptide; Receptors, Pituitary Hormone-Regulating Hormone; Temozolomide | 2009 |
Dopamine agonist-resistant prolactinomas.
Topics: Antineoplastic Agents, Alkylating; Cell Division; Dacarbazine; Dopamine Agonists; Drug Resistance, Neoplasm; Female; Humans; Male; Mitotic Index; Neoplasm Invasiveness; Pituitary Neoplasms; Prolactin; Prolactinoma; Receptors, Estrogen; Sex Factors; Temozolomide | 2011 |
Temozolomide in the management of dopamine agonist-resistant prolactinomas.
Topics: Adolescent; Adult; Dacarbazine; Dopamine Agonists; Drug Resistance, Neoplasm; Humans; Male; Prolactinoma; Temozolomide | 2012 |
15 other study(ies) available for dacarbazine and Adenoma, Prolactin-Secreting, Pituitary
| Article | Year |
|---|---|
Temozolomide treatment can improve overall survival in aggressive pituitary tumors and pituitary carcinomas.
Topics: ACTH-Secreting Pituitary Adenoma; Adult; Antineoplastic Agents, Alkylating; Carcinoma; Chemoradiotherapy; Cohort Studies; Dacarbazine; Drug Resistance, Neoplasm; Female; Follow-Up Studies; France; Humans; Male; Neoplasm Grading; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Pituitary Neoplasms; Practice Patterns, Physicians'; Prolactinoma; Retrospective Studies; Survival Analysis; Temozolomide; Tumor Burden | 2017 |
Failure of a second temozolomide cycle in a patient with a prolactin-secreting pituitary carcinoma.
Topics: Aged; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Bromocriptine; Cabergoline; Combined Modality Therapy; Dacarbazine; Drug Substitution; Ergolines; Fatal Outcome; Headache; Humans; Hyperprolactinemia; Liver Neoplasms; Male; Neoplasm Recurrence, Local; Pituitary Neoplasms; Prolactin; Prolactinoma; Proton Therapy; Temozolomide | 2017 |
Successful treatment of leptomeningeally metastasised pituitary carcinoma with temozolomide.
Topics: Aged; Antineoplastic Agents, Alkylating; Dacarbazine; Humans; Male; Meningeal Neoplasms; Pituitary Neoplasms; Prolactinoma; Spinal Cord Neoplasms; Temozolomide | 2017 |
Treatment of aggressive prolactinoma with temozolomide: A case report and review of literature up to date.
Topics: Adolescent; Antineoplastic Agents, Alkylating; Dacarbazine; Humans; Male; Pituitary Neoplasms; Prolactin; Prolactinoma; Salvage Therapy; Temozolomide | 2017 |
Temozolomide retreatment in a recurrent prolactin-secreting pituitary adenoma: Hormonal and radiographic response.
Topics: Adenoma; Antineoplastic Agents, Alkylating; Dacarbazine; Female; Humans; Magnetic Resonance Imaging; Middle Aged; Neoplasm Recurrence, Local; Pituitary Neoplasms; Prolactin; Prolactinoma; Retreatment; Temozolomide; Treatment Outcome | 2016 |
Successful treatment of a child with a prolactin secreting macroadenoma with temozolomide.
Topics: Antineoplastic Agents, Alkylating; Child; Dacarbazine; Female; Humans; Pituitary Neoplasms; Prognosis; Prolactin; Prolactinoma; Temozolomide | 2016 |
Temozolomide treatment of a pituitary carcinoma and two pituitary macroadenomas resistant to conventional therapy.
Topics: Antineoplastic Agents, Alkylating; Dacarbazine; Drug Resistance, Neoplasm; Female; Hormones; Humans; Immunohistochemistry; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; O(6)-Methylguanine-DNA Methyltransferase; Paraffin Embedding; Pituitary Neoplasms; Positron-Emission Tomography; Prolactin; Prolactinoma; Temozolomide; Young Adult | 2009 |
A novel use of temozolomide in a patient with malignant prolactinoma.
Topics: Antineoplastic Agents, Alkylating; Dacarbazine; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactinoma; Temozolomide | 2009 |
Temozolomide-induced inhibition of pituitary adenoma cells.
Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Dacarbazine; Enzyme-Linked Immunosorbent Assay; In Situ Nick-End Labeling; Mice; Prolactin; Prolactinoma; Rats; Temozolomide; Tumor Cells, Cultured | 2011 |
Temozolomide treatment in aggressive pituitary tumors and pituitary carcinomas: a French multicenter experience.
Topics: ACTH-Secreting Pituitary Adenoma; Adult; Antineoplastic Agents, Alkylating; Carcinoma; Dacarbazine; DNA Methylation; Female; France; Humans; Male; Middle Aged; Neoplasm Invasiveness; O(6)-Methylguanine-DNA Methyltransferase; Pituitary Neoplasms; Prolactinoma; Retrospective Studies; Sequence Analysis, DNA; Temozolomide | 2010 |
A mechanism of acquiring temozolomide resistance during transformation of atypical prolactinoma into prolactin-producing pituitary carcinoma: case report.
Topics: Antineoplastic Agents, Alkylating; Carcinoma; Cell Transformation, Neoplastic; Dacarbazine; DNA Modification Methylases; DNA Repair Enzymes; DNA-Binding Proteins; Drug Resistance, Neoplasm; Fatal Outcome; Female; Humans; Immunohistochemistry; Middle Aged; Mutation; Pituitary Neoplasms; Prolactin; Prolactinoma; Temozolomide; Tumor Suppressor Protein p53; Tumor Suppressor Proteins | 2011 |
Craniofacial fibrous dysplasia and hypophysial microadenoma with Hodgkin's lymphoma: unusual involution of an extensive case.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Disease Progression; Doxorubicin; Female; Fibrous Dysplasia of Bone; Hodgkin Disease; Humans; Mandibular Diseases; Pituitary Neoplasms; Prolactinoma; Vinblastine | 2006 |
Antitumour effects of temozolomide in a man with a large, invasive prolactin-producing pituitary neoplasm.
Topics: Antineoplastic Agents; Dacarbazine; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactinoma; Temozolomide | 2006 |
Temozolomide therapy in a man with an aggressive prolactin-secreting pituitary neoplasm: Morphological findings.
Topics: Antineoplastic Agents, Alkylating; Dacarbazine; Humans; Male; Microscopy, Electron; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma; Temozolomide; Treatment Outcome | 2007 |
Temozolomide in the treatment of an invasive prolactinoma resistant to dopamine agonists.
Topics: Dacarbazine; Dopamine Agonists; Drug Resistance, Neoplasm; Female; Humans; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma; Temozolomide | 2007 |